Related Experiment Video
Updated: Aug 19, 2026

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Minimally invasive coronary artery bypass grafting for myocardial muscle bridging
J W Pratt1, R E Michler, J Pala
1Division of Cardiothoracic Surgery and Division of Cardiology, The Ohio State University, Columbus 43210-1228, USA.
Insights
Myocardial bridging, a congenital heart defect, can cause serious issues. Minimally invasive bypass surgery offers a viable alternative for patients with severe symptoms, avoiding traditional open-heart procedures.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Surgical Innovation
Background:
- Myocardial bridging is a congenital anomaly affecting the left anterior descending coronary artery (LAD).
- It is linked to significant cardiovascular events, including ischemia, infarction, arrhythmias, and sudden cardiac death.
- Medical management often proves insufficient for symptomatic cases.
Observation:
- Two cases of symptomatic myocardial bridging, unresponsive to medical therapy, were successfully treated.
- The treatment involved minimally invasive coronary artery bypass grafting (CABG).
- Crucially, the procedure was performed without cardiopulmonary bypass.
Findings:
- Minimally invasive CABG without cardiopulmonary bypass effectively managed symptomatic myocardial bridging.
- This approach provided a successful alternative to other interventions.
- Patient outcomes suggest the efficacy of this surgical technique.
Implications:
- Minimally invasive CABG is a suitable alternative to stent placement, muscle division, or traditional CABG with cardiopulmonary bypass.
- This technique offers a less invasive option for symptomatic myocardial bridging.
- It expands treatment possibilities for this congenital anomaly.
Abstract:
Myocardial bridging is a congenital anomaly of the left anterior descending coronary artery (LAD), which is associated with myocardial ischemia and infarction, cardiac arrhythmias, and sudden cardiac death. Two cases are reported of symptomatic myocardial bridging refractory to medical management treated by minimally invasive coronary artery bypass grafting without cardiopulmonary bypass. We conclude that minimally invasive coronary artery bypass techniques are appropriate alternatives to endovascular stent placement, muscle bridge division, or aortocoronary grafting with cardiopulmonary bypass for the management of symptomatic myocardial bridging.
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023